Literature DB >> 9630136

Influenza vaccinations of Washington state Medicare beneficiaries seen by physiatrists in the outpatient setting in 1994.

L Chan1, P M Houck, R A Rosenblatt, G Hart, L M Baldwin.   

Abstract

OBJECTIVE: To compare influenza vaccination billing rates for patients seen by physiatrists with those of four other specialties: neurology, rheumatology, family practice, and internal medicine.
DESIGN: Retrospective cohort analysis using Medicare billing data. PATIENTS: 234,164 Medicare outpatients seen in Washington state between September 1 and December 31, 1994.
RESULTS: Based on Medicare's billing data, only 6 of 99 physiatrists ordered vaccinations, and they immunized only 159 (6%) of the patients seen. An additional 1,109 (42%) patients seen by physiatrists were vaccinated by other physicians. Physiatric patients were less likely to have been vaccinated than those seen by internists, family practitioners, or rheumatologists (p < .002), but equally likely as those seen by neurologists (p = .07). A significantly smaller percentage of physiatrists ordered vaccinations than all other specialties (p < .04). Utilizing pre-existing survey data, the misclassification rate (those immunized but not billed) was estimated at 22% of our original cohort. Thus, approximately 800 patients, one third of those seeing physiatrists, may not have been immunized. We estimated the increase in hospitalization costs to be $117 per nonvaccinated patient (total >$90,000).
CONCLUSIONS: Missed opportunities for vaccination by physiatrists appear to be more frequent than in other specialties and have potentially large health and economic costs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630136     DOI: 10.1016/s0003-9993(98)90031-4

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  1 in total

1.  New CDC recommendations: annual influenza vaccination recommended for individuals with spinal cord injuries.

Authors:  Barry Goldstein; Frances M Weaver; Margaret C Hammond
Journal:  J Spinal Cord Med       Date:  2005       Impact factor: 1.985

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.